These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7419327)

  • 1. Strategy for rubella vaccination.
    Knox EG
    Int J Epidemiol; 1980 Mar; 9(1):13-23. PubMed ID: 7419327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computer assessment of alternative rubella vaccination strategies in New Zealand.
    Riseley RC; Smith AH; Laugesen M; Chapman CJ
    N Z Med J; 1983 Apr; 96(729):235-8. PubMed ID: 6572834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination against rubella in Britain: benefits and risks.
    Freestone DS
    Dev Biol Stand; 1979; 43():339-48. PubMed ID: 520680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of rubella vaccine policy for the UK.
    Knox EG
    Int J Epidemiol; 1987 Dec; 16(4):569-78. PubMed ID: 3440667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Has the United States population been adequately vaccinated to achieve rubella elimination?
    Bloom S; Smith P; Stanwyck C; Stokley S
    Clin Infect Dis; 2006 Nov; 43 Suppl 3():S141-5. PubMed ID: 16998773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the Effectiveness and Cost-Benefit of Test-and-Vaccinate Policy for Supplementary Vaccination against Rubella with Limited Doses.
    Saito MM; Ejima K; Kinoshita R; Nishiura H
    Int J Environ Res Public Health; 2018 Mar; 15(4):. PubMed ID: 29565821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubella.
    Robertson SE; Cutts FT; Samuel R; Diaz-Ortega JL
    Bull World Health Organ; 1997; 75(1):69-80. PubMed ID: 9141752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Informing rubella vaccination strategies in East Java, Indonesia through transmission modelling.
    Wu Y; Wood J; Khandaker G; Waddington C; Snelling T
    Vaccine; 2016 Nov; 34(46):5636-5642. PubMed ID: 27670077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rubella vaccination in India: identifying broad consequences of vaccine introduction and key knowledge gaps.
    Winter AK; Pramanik S; Lessler J; Ferrari M; Grenfell BT; Metcalf CJE
    Epidemiol Infect; 2018 Jan; 146(1):65-77. PubMed ID: 29198212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulations of rubella vaccination strategies in China.
    Gao L; Hethcote H
    Math Biosci; 2006 Aug; 202(2):371-85. PubMed ID: 16603207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Models of strategies for control of rubella and congenital rubella syndrome-a 40 year experience from Australia.
    Gao Z; Wood JG; Burgess MA; Menzies RI; McIntyre PB; MacIntyre CR
    Vaccine; 2013 Jan; 31(4):691-7. PubMed ID: 23196206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the dynamic effects of rubella vaccination programmes.
    de Boo TM; van Druten JA; Plantinga AD
    Stat Med; 1987; 6(7):843-51. PubMed ID: 3423505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rubella vaccination of schoolgirls: factors affecting vaccine uptake.
    Peckham CS; Marshall WC; Dudgeon JA
    Br Med J; 1977 Mar; 1(6063):760-1. PubMed ID: 856383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we prevent an increase in the incidence of congenital rubella syndrome in the next decade?
    Coulombe L; Rosser WW
    Can Med Assoc J; 1981 Jul; 125(1):37-40. PubMed ID: 7260807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rubella vaccine coverage and seroprotection in 11-year-old children in the Indre-et-Loire department].
    Bourderioux C; Hubert B; Vol S; Feyt M; Drucker J; Tichet J
    Arch Pediatr; 1994 Oct; 1(10):941-3. PubMed ID: 7842078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rubella vaccination: remaining problems.
    Banatvala JE
    Br Med J (Clin Res Ed); 1982 May; 284(6325):1285-6. PubMed ID: 6803940
    [No Abstract]   [Full Text] [Related]  

  • 19. Measles, mumps, and rubella: the need for a change in immunisation policy.
    Walker D; Carter H; Jones IG
    Br Med J (Clin Res Ed); 1986 Jun; 292(6534):1501-2. PubMed ID: 3087495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of immunity against rubella in Iranian after mass campaign for measles-rubella vaccination on December 2003.
    Hamkar R; Jalilvand S; Mokhtari-Azad T; Jelyani KN; Nategh R
    Am J Infect Control; 2006 Nov; 34(9):588-92. PubMed ID: 17097454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.